Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roger von Moos

Showing results (31-40 of 129) with videos related to

Pageof 13
Sort By:
Cancer Treatment Reviews|May 29, 2019
Management of bone health in solid tumours: From bisphosphonates to a monoclonal antibodyRoger von Moos, Luis Costa, Eva Gonzalez-Suarez, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|November 11, 2015
Weekly carboplatin in combination with weekly paclitaxel in the treatment of metastatic non-small cell lung cancer: a single center 10-year experienceViktoria Volk, Richard Cathomas, Michael Mark, et al.
Oncology|May 25, 2011
Self-reported compliance with capecitabine: findings from a prospective cohort analysisRalph Winterhalder, Pierre Hoesli, Geoffrey Delmore, et al.
Oncology|July 16, 2005
Current concepts of treatment strategies in advanced or recurrent ovarian cancerMarc Salzberg, Beat Thurlimann, Hervé Bonnefois, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|September 17, 2009
Heated (37 degrees C) oxaliplatin infusion in combination with capecitabine for metastatic colorectal carcinoma: can it reduce neuropathy?Richard Cathomas, Dieter Köberle, Thomas Ruhstaller, et al.
Clinical Colorectal Cancer|April 28, 2016
Bevacizumab Continuation Versus Treatment Holidays After First-Line Chemotherapy With Bevacizumab in Patients With Metastatic Colorectal Cancer: A Health Economic Analysis of a Randomized Phase 3 Trial (SAKK 41/06)Klazien Matter-Walstra, Matthias Schwenkglenks, Daniel Betticher, et al.
Acta Oncologica (Stockholm, Sweden)|May 31, 2017
PET-CT guided SIB-IMRT combined with concurrent 5-FU/MMC for the treatment of anal cancerMichel Zimmermann, Jürgen Beer, Stefan Bodis, et al.
Onkologie|September 15, 2010
Long-term renal safety profile of ibandronate 6 mg infused over 15 minutesRoger von Moos, Clemens B Caspar, Rolf Steiner, et al.
Swiss Medical Weekly|January 21, 2025
A cost-effectiveness analysis of sotorasib as second-line treatment for patients with KRAS-G12C-mutated metastatic non-small cell lung cancer (mNSCLC) in SwitzerlandTämer El Saadany, Judith Lupatsch, Michael Mark, et al.
Oncology Research and Treatment|May 24, 2014
Pre-existing antihypertensive treatment predicts early increase in blood pressure during bevacizumab therapy: the prospective AVALUE cohort studyAndreas Wicki, Frank Hermann, Vincent Prêtre, et al.
Pageof 13

Showing results (31-40 of 129) with videos related to

Sort By:
Pageof 13
Cancer Treatment Reviews|May 29, 2019
Management of bone health in solid tumours: From bisphosphonates to a monoclonal antibodyRoger von Moos, Luis Costa, Eva Gonzalez-Suarez, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|November 11, 2015
Weekly carboplatin in combination with weekly paclitaxel in the treatment of metastatic non-small cell lung cancer: a single center 10-year experienceViktoria Volk, Richard Cathomas, Michael Mark, et al.
Oncology|May 25, 2011
Self-reported compliance with capecitabine: findings from a prospective cohort analysisRalph Winterhalder, Pierre Hoesli, Geoffrey Delmore, et al.
Oncology|July 16, 2005
Current concepts of treatment strategies in advanced or recurrent ovarian cancerMarc Salzberg, Beat Thurlimann, Hervé Bonnefois, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|September 17, 2009
Heated (37 degrees C) oxaliplatin infusion in combination with capecitabine for metastatic colorectal carcinoma: can it reduce neuropathy?Richard Cathomas, Dieter Köberle, Thomas Ruhstaller, et al.
Clinical Colorectal Cancer|April 28, 2016
Bevacizumab Continuation Versus Treatment Holidays After First-Line Chemotherapy With Bevacizumab in Patients With Metastatic Colorectal Cancer: A Health Economic Analysis of a Randomized Phase 3 Trial (SAKK 41/06)Klazien Matter-Walstra, Matthias Schwenkglenks, Daniel Betticher, et al.
Acta Oncologica (Stockholm, Sweden)|May 31, 2017
PET-CT guided SIB-IMRT combined with concurrent 5-FU/MMC for the treatment of anal cancerMichel Zimmermann, Jürgen Beer, Stefan Bodis, et al.
Onkologie|September 15, 2010
Long-term renal safety profile of ibandronate 6 mg infused over 15 minutesRoger von Moos, Clemens B Caspar, Rolf Steiner, et al.
Swiss Medical Weekly|January 21, 2025
A cost-effectiveness analysis of sotorasib as second-line treatment for patients with KRAS-G12C-mutated metastatic non-small cell lung cancer (mNSCLC) in SwitzerlandTämer El Saadany, Judith Lupatsch, Michael Mark, et al.
Oncology Research and Treatment|May 24, 2014
Pre-existing antihypertensive treatment predicts early increase in blood pressure during bevacizumab therapy: the prospective AVALUE cohort studyAndreas Wicki, Frank Hermann, Vincent Prêtre, et al.
Pageof 13